Skip to content

TERMINALIA CHEBULA IN IRRITABLE BOWEL SYNDROME

EFFECTIVENESS OF TERMINALIA CHEBULA MOTHER TINCTURE IN IRRITABLE BOWEL SYNDROME: A SINGLE ARM CLINICAL TRIAL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052377
Enrollment
35
Registered
2023-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Terminalia Chebula Mother Tincture: Intervention is planned as administering Terminalia chebula mother tincture in empirical dosage of 05 drops in ½ cup of water twice daily orally, af

Sponsors

RBTS GOVT HOMEO MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both sexes. 2. Patients of 25-40 years of age 3. Patients of all religion and different socio-economic status 4. Patient who gives consent for Homoeopathic treatment 5. Cases which fit into ROMEâ??S IV Criteria 6. Self-reported and pre-diagnosed case of IBS 7. Patient having symptomatology of IBS

Exclusion criteria

Exclusion criteria: 1. Patient suffering from any systemic illness or pathological abnormality 2. Patient who does not give consent for homoeopathic treatment 3. Self-reported immune compromised state 4. Undergoing homoeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

MeasureTime frame
Symptomatology of IBS as per ROMEâ??S IV criteria (number of patient improved or not improved). Timepoint: 0-3 months

Secondary

MeasureTime frame
GSRS-IBS (Gastro-intestinal symptom rating scale for irritable bowel syndrome) scale for quality of life. Timepoint: 0-3 months

Countries

India

Contacts

Public ContactDr VIVEK KUMAR SHAIL

RBTS GOVT HOMOEO MEDICAL COLLEGE AND HOSPITAL MUZ BIHAR 842002

drviknih@gmail.com8298994658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026